Tag: Meningitis
ACIP Approves 2016 Adult Immunization Schedule
Changes to schedule for HPV, pneumococcal, and meningococcal vaccines
Intensified Tx Doesn’t Up Survival in Tuberculous Meningitis
No significant difference for survival, secondary outcomes for standard, intensified treatment
Antineoplastic Agent Obscures Diagnosis of Fungal Meningitis
Cerebrospinal fluid culture results were negative following receipt of capecitabine
Trimethoprim-Induced Aseptic Meningitis Described
Case report describes 87-year-old with 3 episodes; decreasing interval between dose, symptoms
MenB Vaccine Recommended for 16- to 23-Year-Olds
Preferred age for serogroup B meningococcal vaccination is 16 to 18 years
Concomitant Administration of 9vHPV With MCV4/Tdap Feasible
Noninferior to intermittent administration of vaccines for 11- to 15-year olds
ACIP Recommends MenB Vaccine for 16- to 23-Year-Olds
Category B recommendation for short-term protection against meningitis for all aged 16 to 23
Investigational MenB Vaccine Can Protect Individuals in Outbreak
No serogroup B meningococcal disease cases in those who received MenB vaccine in university outbreak
FDA Approves New Meningococcal Disease Vaccine
Bexsero is the second vaccine approved in the past three months to prevent this disease
